Lilra3 binds both classical and non-classical HLA class i molecules but with reduced affinities compared to lilrb1/lilrb2: Structural evidence

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Ryu, Myongchol ^a,b,c   Chen, Yong ^a,b   Qi, Jianxun ^a   Liu, Jun ^a,b   Fan, Zheng ^a   Nam, Gol ^a,b,c   Shi, Yi ^a,b   Cheng, Hao ^a,b   Gao, George F ^a,b,d  

^a INSTITUTE OF MICROBIOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c State Academy of Sciences   (North Korea)

^d INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA G ANTIGEN; HLA G1 ANTIGEN; IMMUNOGLOBULIN RECEPTOR; PROTEIN LILRA3; PROTEIN LILRB1; PROTEIN LILRB2; UNCLASSIFIED DRUG; HLA ANTIGEN CLASS 1; LEUKOCYTE ANTIGEN; LILRA3 PROTEIN, HUMAN; LILRB1 PROTEIN, HUMAN; LILRB2 PROTEIN, HUMAN; MEMBRANE PROTEIN;

AMINO ACID SEQUENCE; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; CRYSTAL STRUCTURE; PROTEIN DOMAIN; PROTEIN FUNCTION; RECEPTOR BINDING; SURFACE PLASMON RESONANCE; CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; HUMAN; HYDROGEN BOND; IMMUNE SYSTEM; KINETICS; METHODOLOGY; MOLECULAR GENETICS; PROTEIN BINDING; PROTEIN TERTIARY STRUCTURE; SEQUENCE HOMOLOGY; X RAY CRYSTALLOGRAPHY;

AMINO ACID SEQUENCE; ANTIGENS, CD; CRYSTALLOGRAPHY, X-RAY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; HYDROGEN BONDING; IMMUNE SYSTEM; KINETICS; MEMBRANE GLYCOPROTEINS; MODELS, MOLECULAR; MOLECULAR CONFORMATION; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, IMMUNOLOGIC; SEQUENCE HOMOLOGY, AMINO ACID; SURFACE PLASMON RESONANCE;

EID: 79955749811     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019245     Document Type: Article

References (46)

1. Ravetch JV, Lanier LL, (2000) Immune inhibitory receptors. Science 290: 84-89.
2. Chen Y, Shi Y, Cheng H, An YQ, Gao GF, (2009) Structural immunology and crystallography help immunologists see the immune system in action: how T and NK cells touch their ligands. IUBMB Life 61: 579-590.
3. Young NT, Canavez F, Uhrberg M, Shum BP, Parham P, (2001) Conserved organization of the ILT/LIR gene family within the polymorphic human leukocyte receptor complex. Immunogenetics 53: 270-278.
4. Colonna M, Navarro F, Bellon T, Llano M, Garcia P, et al. (1997) A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med 186: 1809-1818.
5. Cosman D, Fanger N, Borges L, Kubin M, Chin W, et al. (1997) A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 7: 273-282.
6. Wagtmann N, Rojo S, Eichler E, Mohrenweiser H, Long EO, (1997) A new human gene complex encoding the killer cell inhibitory receptors and related monocyte/macrophage receptors. Curr Biol 7: 615-618.
7. Andre P, Biassoni R, Colonna M, Cosman D, Lanier LL, et al. (2001) New nomenclature for MHC receptors. Nat Immunol 2: 661.
8. Torkar M, Haude A, Milne S, Beck S, Trowsdale J, et al. (2000) Arrangement of the ILT gene cluster: a common null allele of the ILT6 gene results from a 6.7-kbp deletion. Eur J Immunol 30: 3655-3662.
9. Colonna M, Nakajima H, Navarro F, Lopez-Botet M, (1999) A novel family of Ig-like receptors for HLA class I molecules that modulate function of lymphoid and myeloid cells. J Leukoc Biol 66: 375-381.
10. Willcox BE, Thomas LM, Bjorkman PJ, (2003) Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor. Nat Immunol 4: 913-919.
11. Borges L, Hsu ML, Fanger N, Kubin M, Cosman D, (1997) A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules. J Immunol 159: 5192-5196.
12. Colonna M, Samaridis J, Cella M, Angman L, Allen RL, et al. (1998) Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J Immunol 160: 3096-3100.
13. Fanger NA, Cosman D, Peterson L, Braddy SC, Maliszewski CR, et al. (1998) The MHC class I binding proteins LIR-1 and LIR-2 inhibit Fc receptor-mediated signaling in monocytes. Eur J Immunol 28: 3423-3434.
14. Navarro F, Llano M, Bellon T, Colonna M, Geraghty DE, et al. (1999) The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells. Eur J Immunol 29: 277-283.
15. Lepin EJ, Bastin JM, Allan DS, Roncador G, Braud VM, et al. (2000) Functional characterization of HLA-F and binding of HLA-F tetramers to ILT2 and ILT4 receptors. Eur J Immunol 30: 3552-3561.
16. Vitale M, Castriconi R, Parolini S, Pende D, Hsu ML, et al. (1999) The leukocyte Ig-like receptor (LIR)-1 for the cytomegalovirus UL18 protein displays a broad specificity for different HLA class I alleles: analysis of LIR-1+NK cell clones. Int Immunol 11: 29-35.
17. Allen RL, Raine T, Haude A, Trowsdale J, Wilson MJ, (2001) Leukocyte receptor complex-encoded immunomodulatory receptors show differing specificity for alternative HLA-B27 structures. J Immunol 167: 5543-5547.
18. Chen Y, Gao F, Chu F, Peng H, Zong L, et al. (2009) Crystal structure of myeloid cell activating receptor leukocyte Ig-like receptor A2 (LILRA2/ILT1/LIR-7) domain swapped dimer: molecular basis for its non-binding to MHC complexes. J Mol Biol 386: 841-853.
19. Cheng H, Mohammed F, Nam G, Chen Y, Qi J, et al. (2011) Crystal Structure of Leukocyte Ig-like Receptor LILRB4 (ILT3/LIR-5/CD85k): a Myeloid Inhibitory Receptor Involved in Immune Tolerance. J Biol Chem (in press).
20. Shiroishi M, Tsumoto K, Amano K, Shirakihara Y, Colonna M, et al. (2003) Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc Natl Acad Sci U S A 100: 8856-8861.
21. Garner LI, Salim M, Mohammed F, Willcox BE, (2006) Expression, purification, and refolding of the myeloid inhibitory receptor leukocyte immunoglobulin-like receptor-5 for structural and ligand identification studies. Protein Expr Purif 47: 490-497.
22. Shiroishi M, Kajikawa M, Kuroki K, Ose T, Kohda D, et al. (2006) Crystal structure of the human monocyte-activating receptor, "Group 2" leukocyte Ig-like receptor A5 (LILRA5/LIR9/ILT11). J Biol Chem 281: 19536-19544.
23. Borges L, Kubin M, Kuhlman T, (2003) LIR9, an immunoglobulin-superfamily-activating receptor, is expressed as a transmembrane and as a secreted molecule. Blood 101: 1484-1486.
24. Thomas R, Matthias T, Witte T, (2010) Leukocyte immunoglobulin-like receptors as new players in autoimmunity. Clin Rev Allergy Immunol 38: 159-162.
25. Bonetti A, Koivisto K, Pirttila T, Elovaara I, Reunanen M, et al. (2009) A follow-up study of chromosome 19q13 in multiple sclerosis susceptibility. J Neuroimmunol 208: 119-124.
26. Kabalak G, Dobberstein SB, Matthias T, Reuter S, The YH, et al. (2009) Association of immunoglobulin-like transcript 6 deficiency with Sjogren's syndrome. Arthritis Rheum 60: 2923-2925.
27. An H, Chandra V, Piraino B, Borges L, Geczy C, et al. (2010) Soluble LILRA3, a potential natural antiinflammatory protein, is increased in patients with rheumatoid arthritis and is tightly regulated by interleukin 10, tumor necrosis factor-alpha, and interferon-gamma. J Rheumatol 37: 1596-1606.
28. Chapman TL, Heikema AP, West AP Jr, Bjorkman PJ, (2000) Crystal structure and ligand binding properties of the D1D2 region of the inhibitory receptor LIR-1 (ILT2). Immunity 13: 727-736.
29. Chapman TL, Heikeman AP, Bjorkman PJ, (1999) The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18. Immunity 11: 603-613.
30. Shiroishi M, Kuroki K, Rasubala L, Tsumoto K, Kumagai I, et al. (2006) Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d). Proc Natl Acad Sci U S A 103: 16412-16417.
31. Chen Y, Chu F, Gao F, Zhou B, Gao GF, (2007) Stability engineering, biophysical, and biological characterization of the myeloid activating receptor immunoglobulin-like transcript 1 (ILT1/LIR-7/LILRA2). Protein Expr Purif 56: 253-260.
32. Shiroishi M, Kuroki K, Ose T, Rasubala L, Shiratori I, et al. (2006) Efficient leukocyte Ig-like receptor signaling and crystal structure of disulfide-linked HLA-G dimer. J Biol Chem 281: 10439-10447.
33. Willcox BE, Thomas LM, Chapman TL, Heikema AP, West AP Jr, et al. (2002) Crystal structure of LIR-2 (ILT4) at 1.8 A: differences from LIR-1 (ILT2) in regions implicated in the binding of the Human Cytomegalovirus class I MHC homolog UL18. BMC Struct Biol 2: 6.
34. McIntire RH, Sifers T, Platt JS, Ganacias KG, Langat DK, et al. (2008) Novel HLA-G-binding leukocyte immunoglobulin-like receptor (LILR) expression patterns in human placentas and umbilical cords. Placenta 29: 631-638.
35. Gonen-Gross T, Achdout H, Arnon TI, Gazit R, Stern N, et al. (2005) The CD85J/leukocyte inhibitory receptor-1 distinguishes between conformed and beta 2-microglobulin-free HLA-G molecules. J Immunol 175: 4866-4874.
36. Jones DC, Kosmoliaptsis V, Apps R, Lapaque N, Smith I, et al. (2011) HLA class I allelic sequence and conformation regulate leukocyte Ig-like receptor binding. J Immunol 186: 2990-2997.
37. Cao W, Bover L, (2010) Signaling and ligand interaction of ILT7: receptor-mediated regulatory mechanisms for plasmacytoid dendritic cells. Immunol Rev 234: 163-176.
38. Chen Y, Liu P, Gao F, Cheng H, Qi J, Gao GF, (2010) A dimeric structure of PD-L1: functional units or evolutionary relics? Protein Cell 1: 153-160.
39. Gao GF, Willcox BE, Wyer JR, Boulter JM, O'Callaghan CA, et al. (2000) Classical and nonclassical class I major histocompatibility complex molecules exhibit subtle conformational differences that affect binding to CD8alphaalpha. J Biol Chem 275: 15232-15238.
40. Liu J, Sun Y, Qi J, Chu F, Wu H, et al. (2010) The membrane protein of severe acute respiratory syndrome coronavirus acts as a dominant immunogen revealed by a clustering region of novel functionally and structurally defined cytotoxic T-lymphocyte epitopes. J Infect Dis 202: 1171-1180.
41. Read RJ, (2001) Pushing the boundaries of molecular replacement with maximum likelihood. Acta Crystallogr D Biol Crystallogr 57: 1373-1382.
42. Collaborative Computing Project Number 4 (1994) The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr 50: 760-763.
43. Murshudov GN, Vagin AA, Dodson EJ, (1997) Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr 53: 240-255.
44. Emsley P, Cowtan K, (2004) Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60: 2126-2132.
45. Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, et al. (2010) PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66: 213-221.
46. Laskowski RA, Macarthur MW, Moss DS, Thornton JM, (1993) Procheck- a Program to Check the Stereochemical Quality of Protein Structures. Journal of Applied Crystallography 26: 283-291.